Personalized Neoantigen Therapy
Information for clinics, physicians, and patients about next-generation cancer immunotherapy.
Cancer treatment is undergoing a fundamental shift.
Instead of targeting cancer cells with broadly acting therapies, modern immunotherapy aims to train the patient's own immune system to recognize and eliminate cancer cells with high specificity.
One of the most promising approaches within this field is personalized neoantigen therapy.
What Are Neoantigens?
Neoantigens are unique tumor-specific molecular structures on the surface of mutations in cancer cells. They do not exist in healthy tissue, making them ideal targets for highly specific immunotherapy. Monoclonal antibodies, mRNA-based approaches, and adoptive cell therapy are among the most advanced forms of personalized cancer therapy.
How Does Neoantigen Therapy Work?
Tumor Analysis
Genetic material from the tumor is analyzed to identify cancer-specific gene mutations using advanced sequencing.
Neoantigen Identification
Bioinformatics methods are used to determine which mutations may produce tumor-specific neoantigens recognizable to the immune system.
Therapeutic Design
Selected neoantigens are encoded into vaccine constructs using mRNA or peptide-based target arrays.
KUHS LABORATORY does not provide treatments. The bioinformatics platform acts as a coordination and analysis layer in collaboration with certified partner laboratories.
For Clinics & Physicians
Clinics and physicians may use KUHS LABORATORY to access bioinformatics-driven neoantigen identification for their patients. The analysis is performed in coordination with certified laboratories, and results can be integrated into individualized treatment plans, subject to clinical oversight.
For Patients & Families
If you or a family member have been diagnosed with cancer, personalized neoantigen analysis may be an option worth discussing with your physician. KUHS LABORATORY provides a point of contact for patients and families who wish to learn more about this technology.
Request Further Information
Clinics, physicians, and interested individuals may request general information regarding personalized neoantigen technologies and manufacturing capabilities.
Request Information